Felbamate
NDC 65162-686, Felbamate, suspension, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-686
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202385
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65162-686 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FELBAMATE600 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-686-88 | 65162068688 | 237 mL in 1 BOTTLE (65162-686-88) |
| 65162-686-90 | 65162068690 | 473 mL in 1 BOTTLE (65162-686-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2e325d79-d0a4-4af7-b09b-96ee5a5b2a37
Use it
Look up 65162-686 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-686 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-686. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.